Cargando…
Wild-type blocking pcr coupled with internal competitive amplified fragment improved the detection of rare mutation of KRAS
Mutant KRAS proto-oncogene GTPase (KRAS) serves an important role in predicting the development, diagnosis, treatment and efficacy of targeted drug therapies for colorectal cancer. To improve the detection efficacy of trace amount of mutant KRAS, the locked nucleic acid-based method was modified in...
Autores principales: | Peng, Jia, Wei, Kun, Zhao, Xiang, Yang, Ke, Wang, Huan, Zhang, Yang, Guo, Mei, He, Jing, Wu, Haiyan, Li, Yongchuan, Zhao, Na, Huang, Qing, Fu, Weiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547944/ https://www.ncbi.nlm.nih.gov/pubmed/28677778 http://dx.doi.org/10.3892/mmr.2017.6883 |
Ejemplares similares
-
Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations
por: Huang, Jun-Fu, et al.
Publicado: (2015) -
Targeting wild-type KRAS amplified gastroesophageal cancer through combined MEK and SHP2
por: Wong, Gabrielle S., et al.
Publicado: (2018) -
Snapback Primer Mediated Clamping PCR for Detection of EGFR and KRAS Mutations in NSCLC Patients by High Resolution Melting Analysis
por: Sun, Haiyan, et al.
Publicado: (2014) -
Non PCR-amplified Transcripts and AFLP fragments as reduced representations of the quail genome for 454 Titanium sequencing
por: Leroux, Sophie, et al.
Publicado: (2010) -
Developing SHP2-based combination therapy for KRAS-amplified cancer
por: Li, Tianxia, et al.
Publicado: (2023)